Louis DeRidder, a PhD candidate in the Harvard Medical School and MIT HST Program in Medical Engineering and Medical Physics, working in the Langer and Traverso Labs, describes the closed-loop drug delivery he and his team are creating that modernizes chemotherapy administration and gets closer to personalized dosing for better patient outcomes.